A clinical trial evaluates the efficacy and safety of Elian Granules, a Chinese patent medicine, in treating chronic atrophic gastritis. The study is a randomized, double-blind, placebo-controlled trial involving 240 patients across 10 hospitals in China. It aims to assess the impact of Elian Granules on gastric mucosal histology and safety outcomes over a 24-week treatment period.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.